Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation ISET 2017

Failure of Stent Therapy

Presenter: Gary M. Ansel

February 04, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation ISET 2016

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Presenter: Gary M. Ansel

February 07, 2016

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

Presentation

German Multicenter Real-World Registry of Stenting for SFA Disease

Presenter: Hans Krankenberg

October 01, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

Presentation TCT 2013

Stenting Is the First-line Treatment for SFA Disease!

Presenter: J. Michael Bacharach

October 27, 2013

Presentation

Comparison of Surgical Bypass with Angioplasty and Stenting of SFA Disease

Presenter: MB Malas

August 12, 2013

Presentation

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Presenter: Johannes Lammer

July 16, 2013

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

Presentation

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Presenter: 17338|Subhash Banerjee

September 12, 2012

Presentation

Resultados a Largo Plazo para Bypass Primario frente a Angioplasty/Stenting primarios contra Claudicación Intermitente por Enfermedad Oclusiva de la AFS

Presenter: J. Siracuse

February 16, 2012

Presentation

Long-Term Results for Primary Bypass vs. Primary Angioplasty/Stenting for Intermittent Claudication Due to SFA Occlusive Disease

Presenter: J. Siracuse

February 16, 2012

Advertisement

Drug-Coated Therapy for ISR: Review of Options and Data

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Failure of Stent Therapy

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Successfully Traversing the Occluded SFA Stent with a Mid-Stent Puncture

Drug Eluting Femoral Stents Where does it fit in my practice?

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

German Multicenter Real-World Registry of Stenting for SFA Disease

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Stenting Is the First-line Treatment for SFA Disease!

Comparison of Surgical Bypass with Angioplasty and Stenting of SFA Disease

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

COBRA: Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for PAD

Resultados a Largo Plazo para Bypass Primario frente a Angioplasty/Stenting primarios contra Claudicación Intermitente por Enfermedad Oclusiva de la AFS

Long-Term Results for Primary Bypass vs. Primary Angioplasty/Stenting for Intermittent Claudication Due to SFA Occlusive Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content